“Healthcare organizations can’t afford to lose sight of supporting people’s interest in their own health and well-being, their physical needs and their desire for positive outcomes, while being treated with respect and being addressed as a person”
NASHVILLE, Tenn. (PRWEB)
July 20, 2023
The Beryl Institute and Ipsos released findings from the 13th edition of PX Pulse, a survey to track current perspectives on patient experience in healthcare across the United States. This report trends data related to the consumer experience from data first collected pre-pandemic in December 2019 through the second quarter of 2023. This issue reveals that while quality of care and overall care experience slipped since last quarter, trust in healthcare services and providers remains high.
Key findings include:
- Consumer perception of quality and overall experience are slowly declining.
- Cost and affordability remain important issues to consumers, while access to quality hospitals and treatments appeared again this quarter as one of the top five most important issues.
- The importance of experience remains high at 95% with consumers noting health and well-being as the most important reason why.
- While trust in healthcare is high, creating stronger relationships with patients, providers and the community served may be addressed by a strengthened commitment to the human experience.
“Healthcare organizations can’t afford to lose sight of supporting people’s interest in their own health and well-being, their physical needs and their desire for positive outcomes, while being treated with respect and being addressed as a person,” said Jason A. Wolf, PhD, CPXP, President & CEO, The Beryl Institute. “These are the critical levers that will ensure experience can be elevated and reinforce how quality elements are truly central to the overall experience organizations provide.”
To access the latest PX Pulse report, visit here.
###
About the PX Pulse Survey
The Beryl Institute – Ipsos PX Pulse represents a first-of-its-kind effort to elevate understanding of the current perspectives on patient experience in U.S. healthcare.
This effort regularly captures healthcare consumer perspectives of patient experience in the United States, determines the practices and processes that have the greatest impact and influence on healthcare consumers, and tracks how the market sees patient experience evolving over time.
About The Beryl Institute
The Beryl Institute is a global community of healthcare professionals and experience champions committed to transforming the human experience in healthcare. As a pioneer and leader of the experience movement and patient experience profession for more than a decade, the Institute offers unparalleled access to unbiased research and proven practices, networking and professional development opportunities and a safe, neutral space to exchange ideas and learn from others.
We define the patient experience as the sum of all interactions, shaped by an organization’s culture, that influence patient perceptions across the continuum of care. We believe human experience is grounded in the experiences of patients and families, members of the healthcare workforce and the communities they serve.
About Ipsos
Ipsos is one of the largest market research and polling companies globally, operating in 90 markets and employing over 18,000 people.
Our passionately curious research professionals, analysts and scientists have built unique multi-specialist capabilities that provide true understanding and powerful insights into the actions, opinions and motivations of citizens, consumers, patients, customers or employees. Our 75 business solutions are based on primary data from our surveys, social media monitoring, and qualitative or observational techniques. “Game Changers” – our tagline – summarizes our ambition to help our 5,000 clients navigate with confidence our rapidly changing world.
Founded in France in 1975, Ipsos has been listed on the Euronext Paris since July 1, 1999. The company is part of the SBF 120 and the Mid-60 indexes and is eligible for the Deferred Settlement Service (SRD).
ISIN code FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP http://www.ipsos.com
The publication of these findings abides by local rules and regulations.
For more information on Ipsos’ patient experience and healthcare contributions, you can follow Ipsos on LinkedIn and Twitter (@ipsosus).
Share article on social media or email: